Evidence map›Paper›PMID 35784294›Full record

ArticleFrontiers in immunology2022

Common Variable Immunodeficiency and Neurodevelopmental Delay Due to a 13Mb Deletion on Chromosome 4 Including the NFKB1 Gene: A Case Report.

Clara Franco-Jarava, Irene Valenzuela, Jacques G Riviere, Marina Garcia-Prat, Mónica Martínez-Gallo, Romina Dieli-Crimi, Neus Castells, Laura Batlle-Masó, Pere Soler-Palacin, Roger Colobran

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Clara Franco-JaravaImmunology Division, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Irene ValenzuelaDepartment of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Barcelona, Spain.
Jacques G RiviereJeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.
Marina Garcia-PratJeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.
Mónica Martínez-GalloImmunology Division, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Romina Dieli-CrimiImmunology Division, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Neus CastellsDepartment of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Barcelona, Spain.
Laura Batlle-MasóJeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.
Pere Soler-PalacinJeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.
Roger ColobranImmunology Division, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Vall d'Hebron Hospital Universitari · ESUniversitat Autònoma de Barcelona · ESVall d'Hebron Institut de Recerca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Syndromic immunodeficiencies are a heterogeneous group of inborn errors of immunity that can affect the development of non-immune organs and systems. The genetic basis of these immunodeficiencies is highly diverse, ranging from monogenic defects to large chromosomal aberrations. Antibody deficiency is the most prevalent immunological abnormality in patients with syndromic immunodeficiencies caused by chromosomal rearrangements, and usually manifests as a common variable immunodeficiency (CVID)-like phenotype. Here we describe a patient with a complex phenotype, including neurodevelopmental delay, dysmorphic features, malformations, and CVID (hypogammaglobulinemia, reduced pre-switch and switch memory B cells, and impaired vaccine response). Microarray-based comparative genomic hybridization (aCGH) revealed a 13-Mb deletion on chromosome 4q22.2-q24 involving 53 genes, some of which were related to the developmental manifestations in our patient. Although initially none of the affected genes could be linked to his CVID phenotype, subsequent reanalysis identified

Indexed as

AgammaglobulinemiaCommon Variable ImmunodeficiencyPrimary Immunodeficiency DiseasesChromosome AberrationsChromosome DeletionChromosomes, Human, Pair 4Comparative Genomic HybridizationHumansNF-kappa B p50 SubunitNF-kappa B p50 SubunitNFKB1 protein, humanchromosomal rearrangementscommon variable immunodeficiencynfkb1primary immunodeficienciessyndromic immunodeficiencies

Identifiers

PMID35784294
PMCPMC9247144
OpenAlexW4283026321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.